Biotechnology company Advanced Enzyme Technologies announced Q3FY25 results Revenue from operations on consolidated basis increased to Rs 1,691 million in the Q3FY25 from Rs 1,461 million in the Q2FY25, a growth of 16%. Consolidated EBITDA during Q3FY25 stands at Rs 553 million as compared to Rs 424 million during Q2FY25, increase of 30%. Profit before tax stands at Rs 530 million during Q3FY25 as against Rs 422 million in Q2FY25, increase of 26%. Profit after tax grew by 16% and stands at Rs 389 million during Q3FY25 as compared to Rs 334 million during the Q2FY25. Financial costs remained unchanged during Q3FY25 as compared to Q2FY25. Depreciation and Amortization charge for the Q3FY25 is Rs 90 million as compared to Rs 89 million in Q2FY25. Earnings Per Share during Q3FY25 stands at Rs 3.37 as compared to Rs 2.94 in Q2FY25. Result PDF